Skip to content

Clinical trials

Terminated Central Nervous System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Status: Terminated Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20092
20102
20131
20142
20151
20163
20174
20182
20191
20214
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
M.D. Anderson Cancer Center2
Xenon Pharmaceuticals Inc.2
Alkermes, Inc.1
Alzheimer's Disease Expert Lab (ADEL), Inc.1
Alzheon Inc.1
Biogen1
Bracco Diagnostics, Inc1
Cerus Endovascular, Inc.1
Fondation Ophtalmologique Adolphe de Rothschild1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases29
Brain Diseases18
Nervous System Diseases18
Alzheimer Disease10
Dementia9
Mental Disorders9
Neurodegenerative Diseases9
Tauopathies7
Neurocognitive Disorders6
Movement Disorders4

Trials

Showing 51 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.